Activ8rlives News

 

Activ8rlives Adds SmartOne Peak Flow and FEV1 Wireless Meter to its Health Monitoring Solution for Pulmonary Disease Sufferers

Posted on June 6, 2016

The Activ8rlives SmartOne® Peak Flow and FEV1 Meter extends our range of Bluetooth Smart devices, allowing individuals to monitor their lung function from home and send their data via the Activ8rlives4 Health+Wellness App (iOS and Android) to the new Activ8rlives 3.0 online healthcare solution, compliant with the NHS Information Governance ToolKit as a Self-Care tool for patient-generated data.

The SmartOne® Peak Flow and FEV1 Meter helps patients to understand how their lung function changes throughout the week, during periods of ill health, change of medication or as they change weight and activity levels. It measures Peak Expiratory Flow rate (PEF) and Forced Expiratory Flow at 1 second (FEV1) using a non-invasive simple-to-use wireless monitoring technology. The use of a Peak Flow meter is especially useful if patients have Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis (CF) or Bronchiectasis (NCFB).

Peak flow values are often classified into three coloured zones using the traffic light system of measurement according to the American Lung Association: Green, Yellow and Red. The SmartOne and Activ8rlives App automatically stores the highest (best) value and prompts individuals to blow three times as hard and as fast to move the silver balls up the measuring cylinders for their best reading. Within the Activ8rlives account, respiratory patients can set their own ‘normal’ targets or those calculated automatically by the system using the NHANES III population scales.

 

The display above from a female volunteer indicates that her Peak Flow (PEF) and FEV1 are within the Yellow zone and it may mean that there is narrowing of her airways and she needs to start her agreed self-care plan, which may include medication, physio to clear her lungs and possibly seeking reassurance from her medical team.

 

 

Tags: , , , , , , , ,

Share:

Latest Posts

'Aggressive' blood pressure control helps beat dementia, study finds

Posted on August 15, 2019

Asthma+me – the App being trialled to help children manage severe asthma

Posted on August 12, 2019

Asthma+me innovative technology-enabled solution for paediatric asthma is shortlisted for Best Technological Innovation: Digital

Posted on August 9, 2019

Aseptika wins big at West Midlands healthcare innovation awards

Posted on August 5, 2019

Novel medical-grade wearable patent granted to Aseptika for BuddyWOTCH

Posted on July 24, 2019